Zhao Lijun, Zhu Xiaoqiang, Cong Renhuai, Yang Xiangliang, Zhu Yanhong
National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
Joint Laboratory for the Research of Pharmaceutics, Huazhong University of Science and Technology, Wuhan, China.
Front Pharmacol. 2018 Sep 5;9:1019. doi: 10.3389/fphar.2018.01019. eCollection 2018.
Danggui-Baizhu-Tang (DBT), a traditional Chinese medicine decoction, was used for decreasing serum TG and TC remarkably. However, effect of weight control and action mechanism remains confused. In this study, to evaluate the anti-obesity effects, different gradient concentration of DBT (0.59, 1.17 g/kg) or Orlistat (Orl, 15.6 mg/kg; positive control) were administrated by gavage for 8 weeks in C57BL/6J mice which were pretreated with chow or high fat diet (HFD) for 3 months. After administration, significant decrease of body weight and food utilization was observed. It was indicated that concentration of triacylglycerol (TG), total cholesterol (TC), alanine aminotransferase (ALT), aspartate aminotransferase (AST) in serum were reduced strikingly, as well as accumulation of lipid droplets in liver. Meanwhile, DBT treatment could also decrease weight of white adipose tissue (WAT) and size of adipocytes, whereas increase weight of brown adipose tissue (BAT) in mice. Moreover, it was revealed that DBT could elevate rectal temperature by raising expression of uncoupling protein-1 (UCP1) and peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1α), which were attributed to phosphorylation of AMP-activated protein kinase (AMPK). Furthermore, TNF-α and IL-6, obesity-related inflammatory cytokines, were decreased. In conclusion, DBT could stimulate phosphorylation of AMPK to raise expression of UCP1 and PGC-1α, and activate thermogenesis to prevent obesity.
当归白术汤(DBT)是一种中药汤剂,可显著降低血清甘油三酯(TG)和总胆固醇(TC)。然而,其体重控制效果及作用机制仍不明确。在本研究中,为评估其抗肥胖作用,将不同梯度浓度的DBT(0.59、1.17克/千克)或奥利司他(Orl,15.6毫克/千克;阳性对照)经口灌胃给药8周,实验对象为预先用普通饲料或高脂饮食(HFD)喂养3个月的C57BL/6J小鼠。给药后,观察到体重和食物利用率显著下降。结果表明,血清中甘油三酯(TG)、总胆固醇(TC)、丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)的浓度显著降低,肝脏中脂滴的积累也减少。同时,DBT治疗还可降低小鼠白色脂肪组织(WAT)的重量和脂肪细胞大小,而增加棕色脂肪组织(BAT)的重量。此外,研究发现DBT可通过提高解偶联蛋白-1(UCP1)和过氧化物酶体增殖物激活受体-γ共激活因子-1α(PGC-1α)的表达来升高直肠温度,这归因于腺苷酸活化蛋白激酶(AMPK)的磷酸化。此外,肥胖相关炎症细胞因子肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)减少。总之,DBT可刺激AMPK磷酸化,提高UCP1和PGC-1α的表达,并激活产热以预防肥胖。